Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: A case series

BMC Infectious Diseases

Volumn 4, Issue , 2004, Pages

  Slinger, Robert ^a   Desjardins, Marc ^b   McCarthy, Anne E ^b   Ramotar, Karam ^b   Jessamine, Peter ^b   Guibord, Christiane ^b   Toye, Baldwin ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA ENTERICA; SALMONELLA PARATYPHI; SALMONELLOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TYPHOID FEVER; BACTEREMIA; DRUG EFFECT; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PARATYPHOID FEVER; RETROSPECTIVE STUDY; SALMONELLA TYPHI;

ANTI-INFECTIVE AGENTS; BACTEREMIA; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; PARATYPHOID FEVER; RETROSPECTIVE STUDIES; SALMONELLA PARATYPHI A; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 10444237919     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-4-36     Document Type: Article

References (13)

1. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ: Typhoid Fever. N Engl J Med 2002,347: 1770-1782.
2. Crump JA, Barrett TJ, Nelson JT, Angulo FJ: Reevaluating Fluoroquinolone Breakpoints for Salmonella enterica Serotype Typhi and for Non-Typhi Salmonellae. Clin Infect Dis 2003, 37: 75-81.
3. Hakanen A, Kotilainen P, Jalava J, Siitonen A, Huovinen P: Detection of Decreased Fluoroquinolone Susceptibility in Salmonellas and Validation of Nalidixic Acid Screening Test. J Clin Microbiol 1999, 37: 3572-7.
4. NCCLS: Performance Standards for Antimicrobial Susceptibility Testing; Fourteenth Informational Supplement. NCCLS document M100-S14. Wayne, PA : NCCLS 2004.
5. Threlfall EJ, Skinner JA, Ward LR: Detection of Decreased In Vitro Susceptibility to Ciprofloxacin in Salmonella enterica Serotypes Typhi and Parathypi A. J Antimicrob Chemother 2001, 48: 740-1.
6. NCCLS: Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Eighth Edition. NCCLS document M2-A8. Wayne, PA : NCCLS 2003.
7. NCCLS: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard-Sixth Edition. NCCLS document M7-A6. Wayne, PA : NCCLS 2003.
8. Griggs DJ, Gensberg K, Piddock LJ: Mutations in gyrA Gene of Quinolone-Resistant Salmonella Serotypes Isolated from Humans and Animals. Antimicrob Agents Chemother 1996, 40: 1009-13.
9. Brown JC, Shanahan PMA, Jesudason MV, Thomson CJ, Amyes SGB: Mutations Responsible for Reduced Susceptibility to 4-Quinolones in Clinical Isolates of Multi-Resistant Salmonella Typhi in India. J Antimicrob Chemother 1996, 37: 891-900.
10. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B: Interpreting Chromosomal DNA Restriction Patterns Produced by Pulsed-Field Gel Electrophoresis: Criteria for Bacterial Strain Typing. J Clin Microbiol 1995, 33: 2233-9.
11. Wain J, Hoa NTT, Chinh NT, Vinh H, Everett MJ, Diep S, Day NPJ, Solomon T, White NJ, Piddock LJV, Parry CM: Quinolone-Resistant Salmonella typhi in VietNam: Molecular Basis of Resistance and Clinical Response to Treatment. Clin Infect Dis 1997, 25: 1404-1410.
12. John M: Decreasing Clinical Response of Quinolones in the Treatment of Enteric Fever. Indian J Med Sci 2001, 55: 189-94.
13. Hampton MD, Ward LR, Rowe B, Threlfall EJ: Molecular Fingerprinting of Multidrug-Resistant Salmonella enterica Serotype Typhi. Emerg Infect Dis 1998, 4: 317-320.